Sam Slutsky
Analyst-Equity bij Lifesci Advisors LLC (Research)
Profiel
Mr. Sam Slutsky is an Analyst at Lifesci Advisors LLC and an Analyst at LifeSci Capital LLC.
His coverage universe includes a diverse range of therapeutic areas, including oncology and immunology.
He holds a Bachelor of Arts in Economics from the University of Rochester.
Actieve functies van Sam Slutsky
| Bedrijven | Functie | Begin |
|---|---|---|
| Lifesci Advisors LLC (Research) | Analyst-Equity | 01-06-2015 |
LifeSci Capital LLC
 LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013. | Analyst-Equity | 01-01-2015 |
Opleiding van Sam Slutsky
| Rochester Christian University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Lifesci Advisors LLC (Research) | Finance |
LifeSci Capital LLC
LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013. | Finance |
